Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Blood Advances|April 19, 2024
Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphomaSandhya Sharma, Naren U Mehta, Tim Sauer, et al.
World Journal of Surgical Oncology|November 8, 2014
Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstructionMarcel-Philipp Henrichs, Juliane Krebs, Georg Gosheger, et al.
Frontiers in Immunology|November 26, 2025
Reshaping CAR-T cells through overexpression of T cell factor 1Hao Yao, Yuntian Ding, Qian Chen, et al.
Cancers|April 30, 2021
Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin LymphomaFelix Korell, Maria-Luisa Schubert, Tim Sauer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Cells|May 21, 2020
Current Challenges in Providing Good Leukapheresis Products for Manufacturing of CAR-T Cells for Patients with Relapsed/Refractory NHL or ALLFelix Korell, Sascha Laier, Sandra Sauer, et al.
Blood|July 29, 2021
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicityTim Sauer, Kathan Parikh, Sandhya Sharma, et al.
International Journal of Molecular Medicine|June 2, 2023
Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cellsFranziska Eberhardt, Angela Hückelhoven-Krauss, Alexander Kunz, et al.
Leukemia & Lymphoma|January 21, 2012
Transcription factor CCAAT/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphomaNils H Thoennissen, Gabriela B Thoennissen, Sam Abbassi, et al.
Journal for Immunotherapy of Cancer|April 18, 2023
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapySandhya Sharma, Mae Woods, Naren U Mehta, et al.
Pageof 8